But it's not clear how well this works long term
Spending on GLP-1 drugs in Medicare Part D skyrocketed over the past several years, according to a new analysis from KFF
But as scientists and medical professionals, our job is to look past the story and examine the evidence
Laboratory studies have suggested that GLP-1 receptor activation may modulate inflammatory pathways, though the clinical relevance of these findings remains uncertain
Key points Obesity is a risk factor for developing osteoarthritis (OA), gout, rheumatoid arthritis (RA), psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA), and is associated with higher disease activity and/or severity, and worse response to common treatments
Point mutations Genomic DNA, mitochondrial DNA, and cellular RNA species can be attacked by OH (53, 54)